All the synthetic work was done by procuring available laboratory grade reagents and analytical grade solvents. The solvents and reagents were used as such provided by the manufacturer. TLC was performed to monitor the reactions and to determine the purity of the products. All the reported compounds were purified by column chromatography. The melting points of the synthesized compounds were determined in open capillary method, expressed in °C. IR spectra of compounds were recorded on Shimadzu
FT-IR 8400-S spectrophotometer by KBr pellet technique and are expressed in cm
−1.
1H-NMR and
13C-NMR spectra were recorded on Bruker 400 MHz FT-NMR spectrophotometer using DMSO D
6 and CDCl
3 as the solvents and TMS as internal standard (δ ppm). Mass spectra were obtained using LC–MS ACQUITY UPLC mass spectrometer under ES ionization at 70 eV and Time of flight detector. Retention Time (RT) also observed on the same UPLC instrument by maintaining the below mentioned optimized chromatographic condition: Column: C
18 1.7 micron, Flow rate: 0.4 ml/min, Run time: 15 min, Injection volume: 10 µl, Detector: PDA Detector, TOF, Elution: Gradient, Mobile phase: 0.1% FA in water and Acetonitrile, Column temperature: 60 °C.
Mandal S.P., Garg A., Prabitha P., Wadhwani A.D., Adhikary L, & Kumar B.R. (2018). Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies. Chemistry Central Journal, 12, 141.